Use of alternative cerebrospinal fluid‐based biomarkers to help diagnose Xpert‐negative tuberculous meningitis: A case report
Abstract The widely used Xpert MTB/RIF assay, limited by its suboptimal sensitivity, does not perform well as a rule‐out test for tuberculous meningitis. Alternative CSF‐based biomarkers can help determine the microbial etiology of clinical meningitis when standard diagnostic modalities fail.
Main Authors: | Deechit Poudel, Diptee Poudel, Dhiraj Poudel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-07-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.4526 |
Similar Items
-
Raised adenosine deaminase in the cerebrospinal fluid: A tool for the diagnosis of tuberculous meningitis in developing countries
by: Purti A Saini, et al.
Published: (2017-01-01) -
Evaluation of Cerebrospinal fluid adenosine deaminase activity as a complimentary tool in the early diagnosis of tuberculous meningitis in children
by: A Pan, et al.
Published: (2012-09-01) -
Cerebrospinal fluid Gene XPERT (CBNAAT) in children with tuberculous meningitis
by: Annapurna Rai, et al.
Published: (2021-08-01) -
A Hospital Based Study on Estimation of Adenosine Deaminase Activity (ADA) in Cerebrospinal Fluid (CSF) in Various Types of Meningitis
by: Ashok Kumar Agarwal, et al.
Published: (2014-02-01) -
10-Year Retrospective Review of the Etiologies for Meningitis With Elevated Adenosine Deaminase in Cerebrospinal Fluid: Etiologies Other Than TB
by: Joomee Song, et al.
Published: (2022-07-01)